Efficacy of a Didactic Intervention in Anticoagulated Patients (TAOPE Study)
NCT03647254 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1
Last updated 2018-09-27
Summary
Background: Oral anticoagulant drugs represent an essential tool in thrombo-embolic events prevention. Most used are vitamin K antagonists (VKA), which plasma level is monitored measuring prothrombin time using the International Normalized Ratio. If it takes values out of recommended range, the patient will have a higher risk of suffering from thromboembolic or hemorrhagic complications. Previous researches have shown that, at best, only 33% of total patients keep values on therapeutic level.
The investigators intend to improve International Normalized Ratio control figures by a joint didactic intervention based on Junta de Andalucía School for Patients method that will be practiced by anticoagulated patients themselves.
Methods: A randomized clinical trial was carried out at primary care centers from one healthcare area in Malaga (Andalusia, Spain). Study population: patients included on oral anticoagulant therapy program using vitamin K antagonists.
First step: detection of patients on oral anticoagulation program with International Normalized Ratio on therapeutic level during 65% or less over total time. Second step: patients with inappropriate International Normalized Ratio control were practiced a joint didactic intervention "from peer to peer", by a previously trained and expert anticoagulated patient.
Study variables: time on therapeutic levels before and after intervention, sociodemographic variables, vital signs, existence of cardiovascular risk factors, basic blood test, other prescribed drugs, accompanying diseases and social support.
Almost-experimental analytic study with before-after statistical analysis of the intervention. Lineal regression models were applied on main variables results (International Normalized Ratio value, time on therapeutic level) inputting sociodemographic variables, accompanying diseases and social support.
Conditions
- Health Education
- Patient Education as Topic
- Blood Coagulation Tests
Interventions
- BEHAVIORAL
-
Patient education group
Group meetings with educational sessions will be organised in health center. A group educational intervention was practiced to half of the patients, by one expert patient, so that every patient must attend to one group meeting
Sponsors & Collaborators
-
Andaluz Health Service
collaborator OTHER_GOV -
Francisco Javier Navarro Moya
lead OTHER_GOV
Principal Investigators
-
Francisco J Navarro Moya, Enfermera · Servicio de salud pública de Andalucía. Málaga, España
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2020-12-31
- Completion
- 2021-09-01
Countries
- Spain
Study Locations
More Related Trials
-
Patient Training About the Safety of Warfarin Therapy
NCT02757482 ·Status: COMPLETED ·Phase: NA
-
Impact of Telephone Follow-up in Patient's Health-related Quality of Life That Use Warfarin
NCT03125668 ·Status: COMPLETED ·Phase: NA
-
The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
NCT00247702 ·Status: UNKNOWN ·Phase: NA
-
Anti Vitamin K Therapeutic Education
NCT01587053 ·Status: TERMINATED
-
Fiix-prothrombin Time for Monitoring Warfarin
NCT01565239 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Validation of a New Algorithm for Computerized Dosing of Vitamin K Antagonist Therapy
NCT01392040 ·Status: COMPLETED
-
Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme
NCT01809015 ·Status: COMPLETED
-
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin
NCT03516656 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
NCT02776566 ·Status: COMPLETED ·Phase: NA
-
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
NCT00830570 ·Status: COMPLETED
-
Excessive Warfarin Anticoagulation - Causes and Consequences
NCT02761941 ·Status: UNKNOWN
-
Genetic Determinants of Warfarin Anticoagulation Effect
NCT00162435 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Patient's Knowledge of Their NACO Treatment
NCT03323320 ·Status: COMPLETED
-
A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics
NCT02345356 ·Status: COMPLETED
-
Genotype-guided Warfarin Individualized Treatment
NCT02211326 ·Status: COMPLETED ·Phase: NA
-
Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin
NCT00927862 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients
NCT05926518 ·Status: COMPLETED
-
Prospective Trial of a Validated Algorithm for Warfarin Dosing
NCT02705976 ·Status: COMPLETED ·Phase: NA
-
Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters
NCT04066764 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Prothromplex Total (Prothrombin Complex Concentrate) in Oral Anticoagulant Reversal
NCT01159210 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Test the Accuracy of a Prototype Handheld PT/INR Device
NCT01349712 ·Status: UNKNOWN
-
Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer
NCT03180567 ·Status: UNKNOWN ·Phase: NA
-
Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies
NCT02610153 ·Status: COMPLETED
-
Tecarfarin Anti-Coagulation Trial (TACT)
NCT02522221 ·Status: UNKNOWN ·Phase: PHASE3
-
Education Bundle to Decrease Patient Refusal of VTE Prophylaxis
NCT02402881 ·Status: COMPLETED ·Phase: NA